Lupin Ltd (LUPIN)

Company profile

Sector

Pharmaceuticals

Industry

Pharmaceuticals & Biotechnology

Market cap (₹ Cr)

1,09,507.19

Lupin Ltd. is an innovation led transnational pharmaceutical company, which engages in the manufacture of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 18,971 full-time employees. The firm is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The firm has presence in the Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, Gastro-Intestinal, Anti-Infectives and Nonsteroidal Anti Inflammatory Drug therapy segments and is engaged in the Anti-TB and Cephalosporins segments. The firm along with its subsidiaries has manufacturing locations spread across India, United States of America, Mexico and Brazil with trading and other incidental and related activities extending to the global markets. Its complex generics portfolio includes Filgrastim, Pegfilgrastim, Etanercept and Albuterol and others. Its biosimilar products include Lupifil (Filgrastim), Lupifil-P (Peg-Filgrastim) and Etanercept.

Source: finedge · as of 2026-09-29

Price, last year

Last close (₹): 1,922

Source: quantro_screener_metrics_job · as of 2026-10-22

Key figures

P/E

16.48

52-week high

2,529.5

52-week low

1,896.1

Revenue CAGR, 3 years (%)

18.88

Revenue CAGR, 5 years (%)

13.02

EPS CAGR, 3 years (%)

131.11

EPS CAGR, 5 years (%)

34.19

Source: quantro_screener_metrics_job · as of 2026-10-23

Annual summary

Source: finedge · as of 2026-07-21

Shareholding and promoter pledge

Promoter

46.85%

FII

21.71%

DII

25.32%

Public

6.11%

Promoter shares pledged

0%

Source: finedge · as of 2026-03-31

Similar companies

• Cipla Ltd₹ 1,12,584.7 Cr
• Mankind Pharma Ltd₹ 1,06,427 Cr
• Zydus Lifesciences Ltd₹ 1,17,705.45 Cr
• Dr Reddy's Laboratories Ltd₹ 1,00,394.81 Cr
• Aurobindo Pharma Ltd₹ 92,831.47 Cr
• Laurus Labs Ltd₹ 86,501.22 Cr

Source: quantro_company_profiles · as of 2026-10-23

Recent exchange filings

• concall2026-08-12
• quarterly_result2026-08-06
• concall2026-02-17
• quarterly_result2026-02-12
• concall2025-11-12

Source: nse · as of 2026-10-05

Frequently asked questions

What does Lupin Ltd do?

Lupin Ltd. is an innovation led transnational pharmaceutical company, which engages in the manufacture of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 18,971 full-time employees. The firm is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The firm has presence in the Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, Gastro-Intestinal, Anti-Infectives and Nonsteroidal Anti Inflammatory Drug therapy segments and is engaged in the Anti-TB and Cephalosporins segments. The firm along with its subsidiaries has manufacturing locations spread across India, United States of America, Mexico and Brazil with trading and other incidental and related activities extending to the global markets. Its complex generics portfolio includes Filgrastim, Pegfilgrastim, Etanercept and Albuterol and others. Its biosimilar products include Lupifil (Filgrastim), Lupifil-P (Peg-Filgrastim) and Etanercept.

Which sector is Lupin Ltd in?

Lupin Ltd is in the Pharmaceuticals sector, Pharmaceuticals & Biotechnology industry.

What are Lupin Ltd's latest annual revenue and profit?

For the year ended Mar 2026: revenue 27958.03 Cr, profit after tax 5332.84 Cr.

What is the promoter holding and pledge in Lupin Ltd?

Promoter holding is 46.85%; pledged shares are 0.00% of the promoter holding.

Which companies are similar to Lupin Ltd?

Companies in the same sector of similar size: Cipla Ltd, Mankind Pharma Ltd, Zydus Lifesciences Ltd, Dr Reddy's Laboratories Ltd, Aurobindo Pharma Ltd, Laurus Labs Ltd.